K.J. Harrison & Partners’s Pfizer PFE Stock Holding History

K.J. Harrison & Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.64M	Sell	94,003 -25,500	-21%	-$679K	0.43%	62
2025 Q4	$2.98M	Buy	119,503 +54,140	+83%	+$1.37M	0.4%	77
2025 Q3	$1.77M	Buy	65,363 +6,000	+10%	+$148K	0.25%	103
2025 Q2	$1.44M	Sell	59,363 -10,000	-14%	-$233K	0.24%	107
2025 Q1	$1.76M	Sell	69,363 -8,000	-10%	-$209K	0.34%	84
2024 Q4	$2.06M	Sell	77,363 -50,900	-40%	-$1.38M	0.32%	80
2024 Q3	$3.71M	Buy	128,263 +22,000	+21%	+$642K	0.56%	50
2024 Q2	$2.97M	Sell	106,263 -10,450	-9%	-$288K	0.49%	58
2024 Q1	$3.24M	Buy	116,713 +74,912	+179%	+$2.08M	0.5%	59
2023 Q4	$1.2M	Buy	41,801 +4,952	+13%	+$150K	0.2%	115
2023 Q3	$1.22M	Sell	36,849 -20,000	-35%	-$707K	0.28%	89
2023 Q2	$2.08M	Buy	56,849 +20,148	+55%	+$784K	0.38%	80
2023 Q1	$1.5M	Sell	36,701 -18,000	-33%	-$777K	0.3%	97
2022 Q4	$3.8M	Buy	54,701 +18,000	+49%	+$863K	0.74%	38
2022 Q3	$1.61M	Sell	36,701 -19,984	-35%	-$971K	0.57%	65
2022 Q2	$2.98M	Sell	56,685 -10,000	-15%	-$510K	0.8%	29
2022 Q1	$3.45M	Buy	66,685 +33,829	+103%	+$1.76M	0.55%	51
2021 Q4	$1.94M	Sell	32,856 -2,475	-7%	-$123K	0.27%	112
2021 Q3	$1.53M	Sell	35,331 -23,000	-39%	-$1.02M	0.22%	125
2021 Q2	$2.29K	Buy	58,331 +29,666	+103%	+$1.15M	0.24%	93
2021 Q1	$1.04M	Buy	28,665 +5,000	+21%	+$178K	0.16%	147
2020 Q4	$871K	Sell	23,665 -1,952	-8%	-$71.6K	0.14%	166
2020 Q3	$893K	Hold	25,617	–	–	0.18%	134
2020 Q2	$795K	Buy	25,617 +869	+4%	+$29.5K	0.22%	112
2020 Q1	$766K	Hold	24,748	–	–	0.43%	61
2019 Q4	$920K	Sell	24,748 -14,419	-37%	-$514K	0.23%	109
2019 Q3	$1.33M	Buy	39,167 +14,419	+58%	+$524K	0.37%	83
2019 Q2	$1.02M	Hold	24,748	–	–	0.32%	86
2019 Q1	$997K	Sell	24,748 -200	-0.8%	-$8.01K	0.35%	86
2018 Q4	$1.03M	Buy	24,948 +200	+0.8%	+$8.3K	0.63%	50
2018 Q3	$1.03M	Hold	24,748	–	–	0.27%	108
2018 Q2	$852K	Hold	24,748	–	–	0.25%	112
2018 Q1	$833K	Hold	24,748	–	–	0.27%	98
2017 Q4	$850K	Hold	24,748	–	–	0.29%	98
2017 Q3	$838K	Sell	24,748 -21,080	-46%	-$678K	0.29%	97
2017 Q2	$1.46M	Sell	45,828 -5,438	-11%	-$171K	0.57%	62
2017 Q1	$1.66M	Buy	51,266 +5,438	+12%	+$171K	0.68%	46
2016 Q4	$1.41M	Sell	45,828 -5,375	-10%	-$164K	0.56%	52
2016 Q3	$1.65M	Sell	51,203 -58,287	-53%	-$1.95M	0.78%	37
2016 Q2	$3.66M	Sell	109,490 -21,080	-16%	-$673K	1.96%	8
2016 Q1	$3.67M	Sell	130,570 -55,231	-30%	-$1.58M	1.96%	10
2015 Q4	$5.69M	Sell	185,801 -26,348	-12%	-$829K	2.5%	6
2015 Q3	$6.32M	Sell	212,149 -25,507	-11%	-$818K	3.1%	4
2015 Q2	$7.56M	Sell	237,656 -24,375	-9%	-$794K	2.25%	5
2015 Q1	$8.65M	Sell	262,031 -37,101	-12%	-$1.18M	2.52%	4
2014 Q4	$8.84M	Buy	299,132 +49,644	+20%	+$1.42M	2.55%	3
2014 Q3	$7M	Hold	249,488	–	–	1.96%	13
2014 Q2	$7.03M	Buy	249,488 +3,295	+1%	+$93.9K	2%	13
2014 Q1	$7.47M	Hold	246,193	–	–	2.22%	8
2013 Q4	$7.61M	Sell	246,193 -1,476	-0.6%	-$43K	2.24%	10
2013 Q3	$6.75M	Hold	247,669	–	–	2.46%	6
2013 Q2	$6.58M	Buy	+247,669	New	+$6.84M	2.65%	5

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

K.J. Harrison & Partners's PFE Position: Q1 2026 in Review

K.J. Harrison & Partners reduced its Pfizer (PFE) stake by 21% in Q1 2026, selling an estimated $679K and leaving 94,003 shares worth $2.64M. The position accounts for 0.43% of the portfolio, ranked #62.

K.J. Harrison & Partners first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.84M in Q4 2014. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

K.J. Harrison & Partners held 94,003 shares of Pfizer worth $2.64M as of Q1 2026.
K.J. Harrison & Partners sold 25,500 Pfizer shares in Q1 2026, an estimated $679K.
Pfizer made up 0.43% of K.J. Harrison & Partners's portfolio in Q1 2026, its #62 holding.
K.J. Harrison & Partners first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
K.J. Harrison & Partners's Pfizer position peaked at $8.84M in Q4 2014.
2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on K.J. Harrison & Partners's 13F filing for Q1 2026, filed 28 Apr 2026.